These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10209701)

  • 1. The current cardiac safety situation with antihistamines.
    Yap YG; Camm AJ
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():15-24. PubMed ID: 10209701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential cardiac toxicity of H1-antihistamines.
    Yap YG; Camm AJ
    Clin Allergy Immunol; 2002; 17():389-419. PubMed ID: 12113224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation antihistamines: the risk of ventricular arrhythmias.
    DuBuske LM
    Clin Ther; 1999 Feb; 21(2):281-95. PubMed ID: 10211532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic overview of oral second-generation H1 antihistamines.
    González MA; Estes KS
    Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective.
    Shaikh WA
    J Indian Med Assoc; 2000 Jul; 98(7):397-9. PubMed ID: 11143865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations among non-sedating antihistamines: are there real differences?
    Mattila MJ; Paakkari I
    Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmogenic mechanisms of non-sedating antihistamines.
    Yap YG; Camm AJ
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():174-81. PubMed ID: 10444234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V; Cavero I
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions.
    Crumb WJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):261-4. PubMed ID: 10604956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of antihistamines in children.
    Ten Eick AP; Blumer JL; Reed MD
    Drug Saf; 2001; 24(2):119-47. PubMed ID: 11235817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H1-antihistamines and the central nervous system.
    Welch MJ; Meltzer EO; Simons FE
    Clin Allergy Immunol; 2002; 17():337-88. PubMed ID: 12113223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of torsades de pointes in rabbit ventricles perfused with sedating and nonsedating histamine H1-receptor antagonists.
    Gilbert JD; Cahill SA; McCartney DG; Lukas A; Gross GJ
    Can J Physiol Pharmacol; 2000 May; 78(5):407-14. PubMed ID: 10841436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The proarrhythmogenic activity of non-anti-arrhythmia drugs. Is treatment with antihistamines and cisapride safe?].
    Pelov R; Tankova L; Krushkov I
    Vutr Boles; 1999; 31(2-3):5-9. PubMed ID: 10847134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating allergic rhinitis with second-generation antihistamines.
    Nightingale CH
    Pharmacotherapy; 1996; 16(5):905-14. PubMed ID: 8888086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria.
    Jáuregui I; García-Lirio E; Soriano AM; Gamboa PM; Antépara I
    Expert Rev Clin Immunol; 2012 Jan; 8(1):33-41. PubMed ID: 22149338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.
    Zuberbier T
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):9-18. PubMed ID: 21797930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac actions of antihistamines.
    Woosley RL
    Annu Rev Pharmacol Toxicol; 1996; 36():233-52. PubMed ID: 8725389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac safety of second-generation H
    Cataldi M; Maurer M; Taglialatela M; Church MK
    Clin Exp Allergy; 2019 Dec; 49(12):1615-1623. PubMed ID: 31519068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetirizine and loratadine: minimal risk of QT prolongation.
    Prescrire Int; 2010 Feb; 19(105):26-8. PubMed ID: 20455340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.